Collaboration' etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
Collaboration' etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

14 Aralık 2016 Çarşamba

Bridging the divide: how can the NHS get collaboration right?

In a time of austerity and strained budgets, it has never been more essential for the NHS to get partnerships and collaboration right. Every day, clinical teams save lives – and if the NHS is to survive and thrive, it must draw on this collective strength. Yet collaboration can be patchy among the higher echelons of the NHS, with many potential partners complaining of the health service’s seeming inability to work effectively and courteously with others.


Would the NHS be in a different place if health leaders had, over the past 20 years, facilitated collaboration in the same way they had done for competition? That was one of the questions from the floor at a seminar hosted by the Guardian and supported by business solutions and technology company Brother.


In front of an audience of invited healthcare professionals, an expert panel, chaired by the Guardian’s public services editor David Brindle, discussed and debated the gaps in healthcare provision in the UK, as well as if – and how – they could be solved by more effective partnerships. Could the health, social care and voluntary sectors work more closely together, how might this be achieved and what would it mean for patients?




Fragmentation means duplication and duplication costs money; we can’t afford that


David Hare


“We too often dish out lazy cliches about different sectors and different parts of the system, whether it be the private sector describing the public sector as inefficient or the public sector [describing the private sector] as ethically questionable,” said David Hare, chief executive of NHS Partners Network, which represents independent sector providers of NHS clinical services. “For the patients, some of those divides are false. Even within the NHS we’ve had divides between primary care and secondary care, physical health and mental health. The future has to look at how to integrate and bring all that together for the service user. If you have that fragmentation, you have an element of duplication; duplication costs money and we can’t afford that in the current climate. We have to work our way through this.”


Integration, or joined-up working, has long been the buzzword of choice among professionals in both health and social care. But years of talking have brought few benefits for the social care and voluntary sectors, which continue to be the “poor relations” of the NHS, according to Grainne Siggins, policy lead at the Association of Directors of Adult Social Services (Adass) and director of adult social services for the London borough of Newham. “There are different cultures across health and care and we shouldn’t underestimate the impact of that in terms of trying to work collaboratively and as partners across a whole system,” she said. Asked if the picture was improving, she replied that it wasn’t, adding: “You’ve only got to look at the approach to sustainability and transformation plans [five-year plans for the future of health and care services in local areas] to see that equality wasn’t important in that partnership.”


There are chinks of light in the gloom, however – areas where improved collaboration is beginning to happen. Take Manchester, where powers and responsibilities for health and social care, among others, have been devolved from national government. John Patterson, a GP and clinical director of of Hope Citadel Healthcare, says people now understand that wellbeing is about a range of factors, including health, housing, friends and diet and that healthcare and social care must reflect that. “A housing officer with 30 years of experience can’t be replaced by an app,” he said. “We need to find out how to get that experience and compassion into the health system. How do we get the experience of a community matron into the social care system? The thing I love most about Manchester is that here we’re trying to do that with and through people.”


Another positive associated with “Devo Manc”, he added, is that people are brave enough to try new things. “We were one of the first organisations in the country to get double-badged workers. We had a care navigator that had a council badge and an NHS badge – somebody who would walk between worlds, find the sickest people and help them the most.”




It’s not so much an austerity issue as about doing the right thing for people


Anu Singh


Anu Singh, director of patient and public participation at NHS England, pointed out that the challenge she faces is that people see partnerships as an accounting trick or something that is about saving money. Instead, she said, people needed to realise that traditional models of healthcare hadn’t worked and hadn’t met the needs in the community. “We’re trying to work differently with localities because we know that if we don’t get housing right – if we don’t have people helping with social isolation – this will add to the pressure on care and things will continue to spiral out of control,” she said. “It’s not so much an austerity issue as about doing the right thing for people.”


She recalled how one GP had told her that when a patient came to him in the past with mental health problems, they would prescribe prozac; now, they can help that patient get a job. She believes this example highlights how the NHS can work differently and more effectively. “As always with health, you have innovators and policy people trying to pull strings in different directions,” she said. “People know we’ve not quite got it right so far – I don’t think all the parts have come together before – but the time is now.”


This was a point that Dr Mahiben Maruthappu, a London-based doctor and social entrepreneur, agreed with. He said that the challenges were social, demographic and economic – and that the frontline and national decision-making bodies were not aligned. “I think the vision in the Five Year Forward View still stands – we need a radical upgrade in prevention, better integration of services, and to overcome fractures between primary and secondary services.”


He also explained how technology could save cash while enforcing a better quality of service by being “an enabler” of healthcare that can support doctors, nurses and patients. “We always ask how the health and care system can be more sustainable – if we allow patients to identify and manage their conditions better, that’s going to relieve a tremendous amount of pressure.”


The panellists agreed that the patient or service user must be at the centre of all decisions and Singh admitted that patients could get “pushed around clinical pathways” in the current system. “If the health service is going to be more sustainable, we need to shift that paradigm,” she said.


A question from an audience member about whether there was too much focus on external partnerships and not enough on bringing a “highly disillusioned” workforce into decisions then prompted the panel to discuss healthcare staff.


Singh said she learned the difference between how those on the frontline and policymakers think when she was trying to introduce a scheme to help clinicians empower patients: “What seemed obvious to the policymakers seemed alien to a lot of the clinicians we were talking to.” Talking initially to those involved in care, to see if they had a solution, is key, she said.


Maruthappu, a doctor himself, pointed out that clinicians work in partnership every day – in multidisciplinary teams made up of doctors, nurses, occupational therapists, physiotherapists and more. He suggested that the model be amplified and replicated higher up.


Siggins, meanwhile, highlighted the importance of getting clinicians involved in social care. Now that local authorities have taken over responsibility for commissioning a range of public health services, GPs need to be involved in conversations, she said: “It’s our job to support GPs so we can support people coming into the system.”


All panellists recognised that the current work climate is a difficult one for everyone – but will this strain drive people working in the health, social and voluntary sectors apart? Hare acknowledged the danger, but pointed out that this has only made collaboration more necessary. “We’ve got no alternative. We’re going to have to do things differently. There isn’t going to be a magic pot of money.”


Maruthappu agreed: “Healthcare is a team sport and we need to embrace that far better than we do at the moment.”


At the table


  • David Brindle (chair), public services editor, the Guardian

  • Dr Mahiben Maruthappu, co-founder, NHS Innovation Accelerator

  • Anu Singh, director of patient and public voice and insight, NHS England

  • David Hare, chief executive, NHS Partners Network

  • Grainne Siggins, policy lead, Adass, and director of adult social services, London borough of Newham

  • Dr John Patterson, co-founder, Focused Care scheme


Bridging the divide: how can the NHS get collaboration right?

31 Mayıs 2014 Cumartesi

ASCO 2014: How Scientific Collaboration Can Boost Our Strategy To Fighting Cancer

Though overall age-adjusted death rates for cancer in the US have declined in the previous decade, inform that to about half a million individuals who will get a cancer diagnosis this year, according to data from the American Cancer Society (ACS) and the Nationwide Cancer Institute (NCI). The shock and emotional soreness related with the 6 letter word are devastating.


With considerable national and personal expenditures in grownup cancer investigation leading to higher survival and high quality of daily life for some cancers (breast), accomplishment at treating other cancers (pancreatic) has not yet been attained. The unique biology of specified tumors and their potential to mutate has largely prevented researchers from unlocking the crucial to obtaining larger 5-12 months survival charges.


With new techniques obtainable to fight cancer, like a novel strategy recognized as “immune modulation” helping to accomplish substantial gains in longevity for patients with melanoma and specific varieties of lung cancer, it is crucial to nevertheless recognize that a lot operate demands to be accomplished in our fight against cancer.



David H. Koch Institute for Integrative Cancer...

David H. Koch Institute for Integrative Cancer Investigation (Photo credit: Wikipedia)




Keeping this in mind, academic institutions have begun to comprehend the worth of data sharing and scientific collaboration in an try to discover new treatment options and modalities to approach cancer, both in kids and grownups. The days of study groups competing towards one particular one more hunting at related conceptual puzzles is now getting replaced by unified approaches with so-named “dream teams”–groups of focused researchers whom freely collaborate between institutions–pioneered by the organization Stand Up To Cancer, (SU2C) according to Philip Sharp, Ph.D, Nobel Laureate, Institute Professor at MIT’s David H. Koch Institute for Integrative Cancer Investigation, and Chair of the Scientific Advisory Committee for SU2C.


Unknown“This superb concept of S2UC– of collaboration and bringing together teams of scientists that compliment one particular other– and raising money by appealing to the public and massive donors changed the fashion of cancer analysis by making it far more collaborative and interactive discipline,” explained Sharp. “I located the vision compelling and knew this would be a really public face of cancer research and wanted it to be as higher a quality and have as large an affect as it possibly could.”


Dr. Sharp PhotoAs Sharp explains, SU2C appeals to professionals in the area of cancer study and standard science relevant to a targeted concept. It is not meant to duplicate fundamental science work completed by NCI or sophisticated cancer therapeutics investigations in the personal sector, as Sharp explained, particularly in the context of discussing translational investigation which ideally has a shorter time to reach patients.


“We have tried to uncover the very best teams that have representatives from those communities and then leverage them with what we feel are proximal breakthroughs that have not been moved to translation as fast as attainable and put money there and make that come about,” described Sharp.  “People who are donating this income want to see the advantages of these new approaches as fast as feasible.”


Although the conceptual theme of immune modulation was component of the early perform of the early dream teams in accordance to Sharp, the notion of “personalized medicine”–designing therapeutics following identifying a certain mutation in a cancer cell has been a viable technique going forward. “We have also produced a significant investment in the immune strategy to cancer analysis as nicely.”


Sharp’s research in the preliminary stages of his profession targeted on the molecular biology of gene expression and RNA splicing in cancer cells. In 1977, he elucidated the mechanism of RNA splicing, and identified that genes contain so-known as “nonsense” segments which are edited or eliminated by cells as they procedure genetic data. This approach is integral to the comprehending of the genetic basis for cancer and illness progression, and Sharp was subsequently awarded the 1993 Nobel Prize in Physiology or Medication for this discovery. His research is now  focused on comprehending how specific molecules of RNA can activate certain genes, referred to as RNA interference. This has altered how researchers strategy cell biology and may be a new supply of therapeutics in the long term.


Sharp’s dedication to SU2C more than the previous six many years, has led to a adjust in the paradigm of how we technique cancer remedy. As co-founder of Biogen (now Biogen Idec), and Alnylam Pharmaceuticals, an early stage therapeutics firm and Magen Biosciences Inc., a biotechnology organization developing compounds to make certain well being of human skin, Sharp has been a pioneer in selling the use of molecular biology and genomics, and now “convergence,” as approaches to more efficient drug growth.


And, as he detailed in a white paper from MIT in 2011, the concept of “convergence”–the merging of existence sciences, physical sciences and engineering is now generally viewed as an critical method to perform meaningful investigation to obtain viable solutions to cancer biology and therapy in 2014.  As Sharp emphasizes, convergence represents the so-named threerd “frontier” in the progression from the first two milestones accomplished in the past thirty many years: the advent of cell and molecular biology and genomic sequencing.


Employing such “dream teams” to method breast, pancreatic, melanoma and lung cancers fosters collaboration amid huge academic institutions, even though promoting the concept of “translational medicine” as an efficient way to carry laboratory advances to the bedside, in accordance to Sharp. For this novel strategy,  S2UC researchers are viewed as leaders in their strategy to streamlining cancer analysis.


Unknown-1


St. Jude Children’s Investigation Hospital, a worldwide leader in pioneering pediatric cancer diagnosis and therapy, is also a participant in shared information and collaboration among other institutions, in accordance to Leslie Robison, Ph.D, Chair of the Division of Epidemiology and Cancer Handle, and Associate Director for Cancer Prevention and Control at St. Jude Children’s Research Hospital.


“One of the major charges of our institution is to deal with patients, perform substantial quality investigation, but to make positive we disseminate that study as broadly and widely as feasible,” explained Robison.  “We help to disseminate and facilitate getting access to our information.”



ASCO 2014: How Scientific Collaboration Can Boost Our Strategy To Fighting Cancer

13 Mart 2014 Perşembe

Cegedim and Docnet Provide "Purposeful Collaboration" To Redefine The Physician Social Network

Cegedim has taken a dive into doctor social networks.  Recently, I spoke with Angela Miccoli, President – North America for Cegedim Relationship Management, to get a better sense of how Docnet will engage physicians and Cegedim’s expectations for the US and worldwide marketplace.  Cegedim has deployed Docnet effectively in almost a dozen other nations, and the investments in Docnet are far more than two many years previous. But its launch into the US market will be each an essential services providing and a important barometer for accomplishment.


A network designed especially for daily life sciences, Docnet is centered on providing time back to today’s occupied doctor. It maximizes crucial providers from income representative engagement and solution sampling – to networking and continuing medical schooling. Miccoli sums up Docnet in basic, however compelling terms:



For doctors right now, there are numerous “distraction activities” they nonetheless have to do in an analog way that take time and attention away from improving their practices and benefitting patients. Docnet gives time back to medical professionals. When a physician can use Docnet to buy samples, discover, facilitate co-pay out cards, look up medication, and go via other processes – in a digital, frictionless, worth oriented method – they can focus much more on individuals and practice transformation.



The bottom line for Cegedim:  Docnet and the doctor audience is worth. Connecting doctor-to-physician like Facebook and LinkedIn is essential, but Docnet will strive, according to Miccoil, to connect doctor-to-articles, physician-to-goal, and sooner or later, physician-to-value.   And it’s this value that can make Docnet much less of another social media network, and a lot more of an crucial practice tool.  And beyond material and engagement, Docnet can make it “safe to be social.” With above 40 many years of compliance information and equipment, Miccoli points out that Cegedim is uniquely positioned to deliver a platform of compliance that meets the strictest expectations and suggestions in the business.


From easy sharing to advancing healthcare care, social networks have the prospective to turn out to be essential equipment for doctors.  Alan Lepofsy, VP and Principal Analyst at Constellation Analysis is a effectively-established advocate of advancing the nature of collaboration, summarizes this central idea in the context of healthcare. “Social networks can be a fantastic way to learn data and connect with men and women, but without having a defined objective, participation in these networks usually swiftly fizzle out. In the healthcare industry, collaboration platforms require to allow doctors to function together close to processes like study, clinical practice and continued schooling.”


In a clinical environment exactly where efficiency is important, Cegedim is leveraging their skills to build a platform that moves past facts and figures to provide the value.  This value will make physicians see social networks with much less apprehension and a greater sense of the two logistical and clinical worth.


Keep Critical! Stick to me on Twitter, LinkedIn and Google+!



Cegedim and Docnet Provide "Purposeful Collaboration" To Redefine The Physician Social Network